Table 4:
Variables | Without neoadjuvant (5271 patients) | With neoadjuvant (1316 patients) | Standardized difference (%) |
---|---|---|---|
Age (years), mean (SD) | 62.7 (9.5) | 60.1 (8.5) | 27 |
Female gender, n (%) | 1226 (23) | 295 (22) | 2 |
BMI (kg/m2), mean (SD) | 25.1 (3.9) | 25.2 (3.9) | 2 |
ppoFEV1%, mean (SD) | 58.7 (19.9) | 56.8 (19.6) | 9 |
CAD, n (%) | 385 (7.3) | 80 (6.1) | 4 |
CVD, n (%) | 131 (2.5) | 31 (2.4) | 0.7 |
Diabetes, n (%) | 159 (3.0) | 30 (2.3) | 4 |
PS >1, n (%) | 487 (9.2) | 121 (9.2) | 0.1 |
BMI: body mass index; CAD: coronary artery disease; CVD: cerebrovascular disease; ppoFEV1: predicted postoperative forced expiratory volume in 1 s; PS: performance score.